Who Survives Mesothelioma and Why?
A new study of National Cancer Institute data aims to better understand who survives mesothelioma and why. Malignant mesothelioma is a highly aggressive cancer of internal membranes. Very few people diagnosed with mesothelioma live longer than 18 months. But researchers around the world are working to change those odds. One important step is to look at the characteristics of those who live longest with the asbestos cancer. NCI Data Shows Who Survives Mesothelioma Scientists at Mount Sinai Medical Center in New York turned to the National Cancer Institute database to get a better picture of who survives mesothelioma. The database contains information reported by mesothelioma doctors from around the country. It includes information about the ages, gender, lifestyle, mesothelioma type, … Continue reading Who Survives Mesothelioma and Why?
BAP1 Can Distinguish Mesothelioma from Other Conditions
German scientists say a protein could help doctors distinguish mesothelioma from other conditions. Malignant mesothelioma is a cancer that grows on the membranes around organs. These membranes are called mesothelial membranes. But other conditions can also grow on mesothelial membranes. One of those conditions is adenomatoid tumors. Adenomatoid tumors are benign but, even under the microscope, their cells can look a lot like malignant mesothelioma. Now, a group of pathologists in Germany say the BAP1 protein can tell these two conditions apart. If doctors can distinguish mesothelioma from other conditions early enough, mesothelioma patients may have better outcomes. BAP1 Loss and Mesothelioma BAP1 is a protein encoded by the BAP1 gene. BAP1 is one of the proteins that helps keep … Continue reading BAP1 Can Distinguish Mesothelioma from Other Conditions
Scientists Say Machine Learning Could Help Diagnose Mesothelioma Earlier
Researchers in Toronto say machine learning could help doctors diagnose mesothelioma earlier. Molecular geneticists at the University of Toronto teamed up with cancer and heart doctors to conduct the new research. The team collected data from hundreds of suspected mesothelioma cases and ran it through different statistical analysis programs. The goal was to see which one was best at determining who had pleural mesothelioma and who did not. The results revealed some important information – both about the machine learning tools and about how doctors might diagnose mesothelioma earlier, even without them. Why Doctors Need to Diagnose Mesothelioma Earlier Mesothelioma is almost always caused by asbestos exposure. In the first few years of the disease, there may be no mesothelioma … Continue reading Scientists Say Machine Learning Could Help Diagnose Mesothelioma Earlier
MIT Study Could Open Door for Inhalable Mesothelioma Treatment
New lung cancer research might help pave the way for an inhalable mesothelioma treatment. MIT cancer researchers teamed up with chemical engineers to test a new method for delivering genetic instructions to lung cells. Mice that inhaled a formula designed to “tell” their lung cells to produce more of a certain protein did exactly that. The team says it’s proof that this could be a viable method for treating cancer in the lungs. Pleural mesothelioma is a lung-related cancer caused by inhaled asbestos. How Would an Inhalable Mesothelioma Treatment Work? The study was led by scientists at MIT’s Koch Center for Integrative Cancer Research. It is based on two things scientists already know about cancer treatment. One is that inhalation … Continue reading MIT Study Could Open Door for Inhalable Mesothelioma Treatment
Avelumab May Offer a Second-Line Option for Recurrent Mesothelioma
People with recurrent mesothelioma may get another chance at treatment with the immunotherapy drug avelumab. Malignant mesothelioma is highly resistant to standard cancer therapies. That means that the asbestos cancer usually comes back, or recurs, even after treatment. The most common treatment for mesothelioma is chemotherapy with Alimta. Alimta is the only drug approved specifically for mesothelioma. Patients with recurrent mesothelioma often have several rounds of chemotherapy with Alimta. But once the standard mesothelioma treatments stop working, patients do not have many options. Now a new study suggests that some cases of recurrent mesothelioma that stop responding to Alimta may respond to avelumab. Considering Avelumab for Recurrent Mesothelioma Bavencio is the brand name for avelumab. It is a type … Continue reading Avelumab May Offer a Second-Line Option for Recurrent Mesothelioma
Researchers Name Six Top Mesothelioma Survival Factors
Researchers at the University of Pittsburgh have named what they say are the top six mesothelioma survival factors. According to their new study, patients with one or more of these factors tend to have better mesothelioma treatment outcomes and live longer. Malignant mesothelioma – also called asbestos cancer – is one of the deadliest forms of cancer. It starts on internal membranes and spreads quickly. There is no cure and the disease is very hard to slow down. Many mesothelioma patients die within 12 to 18 months. But there are cases of much longer mesothelioma survival. Some patients have even lived for decades after mesothelioma treatment. The Pittsburgh researchers wanted to find the mesothelioma survival factors shared by the longest … Continue reading Researchers Name Six Top Mesothelioma Survival Factors
New Study Could Lead to a Mesothelioma Breath Test
A large new study now underway may eventually make it possible to create a mesothelioma breath test. Cancer Research UK has launched a two-year clinical trial of the Breath Biopsy. The Breath Biopsy is a device that detects molecules exhaled by people with cancer. The Need for Early Mesothelioma Detection Malignant mesothelioma is one of the deadliest types of cancer. Most people who get mesothelioma have been exposed to asbestos. By the time they receive a diagnosis, many mesothelioma patients have advanced disease. Late diagnosis is one of the main reasons people with mesothelioma often die within a year. When mesothelioma cancer is in an advanced stage, it is less likely to respond to treatment. Scientists around the world are … Continue reading New Study Could Lead to a Mesothelioma Breath Test
Treatment for Pericardial Mesothelioma: Chemotherapy is Best
Some of the nation’s top cancer researchers say chemotherapy is the best treatment for pericardial mesothelioma. Even surgery does not extend survival as well as chemotherapy. Doctors at the University of Texas reached that conclusion after studying more than 100 cases of pericardial mesothelioma. Surgery is still the most common treatment for pericardial mesothelioma. But the new research suggests that chemotherapy may be better. In the study, chemotherapy and cancer spread were the only factors that seemed to impact mesothelioma survival. What is Pericardial Mesothelioma? Malignant mesothelioma tumors grow on the linings around internal organs. The most common type is pleural mesothelioma which grows near the lungs. Peritoneal mesothelioma on the abdominal lining is the second most common type. Pericardial … Continue reading Treatment for Pericardial Mesothelioma: Chemotherapy is Best
Chemotherapy for Mesothelioma May Work Better with TroVax
UK researchers say a cancer vaccine called Trovax has the potential to boost the power of chemotherapy for mesothelioma. Chemotherapy is the main treatment for malignant pleural mesothelioma. Mesothelioma is a cancer of the lung lining caused by asbestos exposure. It is very hard to treat. Even people who have chemotherapy for mesothelioma do not usually live more than two years after diagnosis. Mesothelioma researchers are always looking for ways to improve chemotherapy for mesothelioma. It is often combined with other treatments like surgery, radiation or immunotherapy. Now, scientists think adding TroVax to mesothelioma chemotherapy may be another good option. What is the TroVax Cancer Vaccine? The TroVax cancer vaccine is made by UK-based Oxford BioMedica. It contains an altered … Continue reading Chemotherapy for Mesothelioma May Work Better with TroVax
Stress in Mesothelioma Patients During the Holidays
Every mesothelioma sufferer feels it, but there is very little data on emotional stress in mesothelioma patients and asbestos-exposed people. That is the conclusion of a group of Italian researchers earlier this year. The study is important to revisit during the holidays when mesothelioma patients may feel pressured to be cheerful. According to the Italian team, mesothelioma sufferers and asbestos-exposed people have some special emotional needs. The few studies that exist on the subject suggest that denying these problems may make people sicker. Studying the Studies The team found 12 studies published between 1980 and 2016 on stress in mesothelioma patients. The number of papers on the emotional needs of asbestos-exposed people was even lower. There were only nine of … Continue reading Stress in Mesothelioma Patients During the Holidays
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."
Get your free copy of
“Surviving Mesothelioma” Today!